Shell Asset Management CO Clovis Oncology, Inc. Transaction History

Shell Asset Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$12.81 - $25.67 $84,276 - $168,882	-6,579 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$11.63 - $32.67 $5,815 - $16,335	-500 Reduced 7.06%	6,579 $118,000
Q2 2018 Aug 10, 2018	SELL	$42.06 - $62.4 $16,866 - $25,022	-401 Reduced 5.36%	7,079 $322,000
Q3 2017 Oct 20, 2017	BUY	$67.17 - $84.81 $502,431 - $634,378	7,480	7,480 $616,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.